Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Perhaps we should abandon the "Umbrella" strategy.

"...We can payout 90% of all our net income though distributions to our shareholders..." umm DIVIDENDS? That's what I wanted to do all along! I considered the "umbrella strategy" a pipedream. You guys really DO need me as CEO! LOL

Share
New Message
Please login to post a reply